Your Doctor Prescribed a Medicine, But Will You Get It?
Seth J. Baum, MD In 2013 Dr. Tom Frieden, Director of the CDC, judiciously proclaimed that “even one preventable death is one too many.” Just three years later we are.. read more
Open
X
Archive for the 'familial hypercholesterolemia' Category
Cardiology News: PCSK9 Inhibitors
by Seth J. Baum MD Recently, there have been several articles discussing the development, efficacy, cost and long-term impact of novel cholesterol lowering drugs – called PCSK9 inhibitors – new.. read more
The Collapse of Modern Medicine – From Bedside to Phone Calls
by Seth J. Baum MD Intending no disrespect to true war veterans, I will tell you that the 1980s was our Vietnam. As medical residents in New York City, the.. read more
Accessing PCSK9 Inhibitors: An Ongoing Bottleneck for Patients and Their Doctors
by Seth J. Baum MD PCSK9 inhibitors are the most significant advance in the management of elevated cholesterol in the last 3 decades. These injectable medications are indisputably revolutionary: They.. read more
Response to Matt Perrone‘s April 20th Associated Press Piece on PCSK9 Inhibitors
by Seth J. Baum MD I was fortunate to have the opportunity to speak at length with Matt Perrone prior to his submitting an April 20th article on the PSCK9.. read more
FH Foundation’s National FH Registry Illustrates U.S. FH Population’s Risk for Early CHD
Important research recently published in the American Heart Association’s journals illustrates that the cardiovascular disease burden and treatment patterns among patients with familial hypercholesterolemia (FH) in the US remain poorly.. read more
PCSK9 Inhibitors: Why Are They Under-Prescribed?
by Seth J. Baum, MD A recent article by Caroline Humer and Ransdell Pierson for Reuters reported on the unexpectedly paltry number of prescriptions for PCSK9 inhibitors, the revolutionary cholesterol.. read more
© Copyright 2012 Preventive Cardiology Inc. All rights reserved.
